Screening op hersenmetastasen bij niet kleincellig longkanker: de psychologische impact van de diagnose asymptomatische hersenmetastasen; een focus groep onderzoek

Screening for brain metastases in lung cancer: the psychological impact of being diagnosed with asymptomatic brain metastases, a qualitative study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28792

Enrollment

Registered

2018-08-02

Start date

2018-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC Non small cell lung cancer niet kleincellig longcarcinoom Lung cancer Longkanker hersenmetastasen Brain metastases psychological impact asymptomatisch Screening qualitatieve study Focus group

Interventions

Focus group (no real intervention)

Eligibility

Inclusion criteria

Inclusion criteria: - Stage IV lung cancer patients diagnosed with asymptomatic brain metastases detected by screening - Stage IV lung cancer patients who were diagnosed in the past with asymptomatic brain metastases - systemic treatment is allowed or - partners of stage IV lung cancer patient with asymptomatic brain metastases

Exclusion criteria

Exclusion criteria: - Inability to interact in focus groups - Other neurologic illness (such as Alzheimer's disease)

Design outcomes

Primary

Measure	Time frame
To explore the psychological impact of being diagnosed with asymptomatic brain metastases for both the patients and their partners	—

Contacts

Public ContactL. Hendriks

Dept of Pulmonary Diseases, MUMC+ PO Box 5800

lizza.hendriks@mumc.nl+31 (0) 43 387 6543

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)